FNY Investment Advisers’s Immunogen Inc IMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-11,420
Closed -$338K 902
2023
Q4
$338K Buy
+11,420
New +$227K 0.38% 54
2018
Q4
Sell
-400
Closed -$3K 1105
2018
Q3
$3K Hold
400
﹤0.01% 696
2018
Q2
$3K Buy
+400
New +$4.22K ﹤0.01% 755

Other funds holding IMGN

FNY Investment Advisers's IMGN Position: Q1 2024 in Review

FNY Investment Advisers sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 11,420 shares — an estimated $338K sold.

FNY Investment Advisers first reported a position in IMGN in Q2 2018 and held it in 3 quarters. The position peaked at $338K in Q4 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

  • FNY Investment Advisers reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
  • FNY Investment Advisers sold 11,420 Immunogen Inc shares in Q1 2024, an estimated $338K.
  • FNY Investment Advisers first reported a position in Immunogen Inc in Q2 2018 and held it in 3 quarters.
  • FNY Investment Advisers's Immunogen Inc position peaked at $338K in Q4 2023.
  • 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on FNY Investment Advisers's 13F filing for Q1 2024, filed 3 May 2024.